Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03048682 · ClinicalTrials.gov registry record · NA
Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery
A NA study of Surgery and Pelvic Organ Prolapse, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT03048682: Completed NA study of Surgery and Pelvic Organ Prolapse, sponsored by The Cleveland Clinic.
NCT03048682 is a NA study of Surgery and Pelvic Organ Prolapse that has completed, run by The Cleveland Clinic. The registered enrollment target is 64 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03048682, a NA study of Surgery and Pelvic Organ Prolapse, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a randomized controlled trial designed to assess the rate of failure of voiding trials in the early and late post-operative period within patients who underwent outpatient pelvic floor surgery that failed initial same day voiding trials.
Primary Outcome
Determine the rates of failed voiding trials in each of the two groups
Conditions Studied
Interventions
- DEVICE Foley catheter - Early Voiding Trial
- DEVICE Foley catheter - Late Voiding Trial
Study Locations (2)
Florida
- Cleveland Clinic Florida - Weston
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-01-05 |
| Est. Completion | 2019-11-30 |
| Phase | NA |
What the finished NCT03048682 record still lists
NCT03048682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Foley catheter - Early Voiding Trial is the first listed.
NCT03048682 reports a single indexed study location in Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03048682 about?
NCT03048682 is a clinical study titled "Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery". This study is a randomized controlled trial designed to assess the rate of failure of voiding trials in the early and late post-operative period within patients who underwent outpatient pelvic floor surgery that failed initial same day voiding trials.
What is the current status of trial NCT03048682?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-01-05. Estimated completion is 2019-11-30.
What conditions does trial NCT03048682 study?
This clinical trial studies the following conditions: Surgery, Pelvic Organ Prolapse, Urinary Incontinence,Stress.
What interventions are being tested in trial NCT03048682?
The interventions under investigation include: Foley catheter - Early Voiding Trial (DEVICE), Foley catheter - Late Voiding Trial (DEVICE).
Who is sponsoring clinical trial NCT03048682?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03048682 being conducted?
This trial has 2 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03048682's enrollment target sits among peer trials
64 79th of 120 higher than 41 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
-
Gastric US in ICU Patient
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI